Budd-Chiari syndrome in China: A 30-year retrospective study on survival from a single center

Figure 1 Flow chart of case selection. BCS: Budd-Chiari syndrome.

Figure 2 Survival rates of Budd-Chiari syndrome patients. A: Comparison of cumulative survival rates of Budd-Chiari syndrome (BCS) between the 188 treated patients and 24 untreated patients. Treated patients had significantly better long-term survival than untreated patients (P = 0.007); B: Comparison of cumulative survival rates of BCS among different treatment modalities. Patients treated by interventional radiology had significantly better long-term survival than patients treated by medicine or surgery (P = 0.002).

Figure 3 Cumulative mortality rates of Budd-Chiari syndrome. A: Cumulative mortality rates of Budd-Chiari syndrome (BCS) patients who died of liver or multiple organ failure; B: Cumulative mortality rates of BCS patients who died of gastroesophageal variceal bleeding; C: Cumulative mortality rates of BCS patients who died of hepatocellular carcinoma.